Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -61.65%10.24B | 171.23%12.77B | -307.60%-4.21B | -180.07%-3.19B | -69.52%4.87B | 178.42%26.7B | 32.22%4.71B | -81.03%2.03B | 116.30%3.99B | -19.38%15.98B |
| Net income from continuing operations | 19.08%8.73B | -0.39%2.3B | 24.93%2.33B | 5.14%1.96B | 65.48%2.14B | 65.13%7.33B | 34.74%2.3B | 19.17%1.87B | 81.34%1.87B | 871.43%1.29B |
| Operating gains losses | -13.51%-462M | -84.11%-197M | 6.93%-94M | 56.76%-64M | -109.80%-107M | -11.51%-407M | 51.14%-107M | -180.56%-101M | -322.86%-148M | 32.00%-51M |
| Depreciation and amortization | 3.32%2.18B | 6.49%558M | 0.57%533M | 3.82%544M | 2.44%545M | 0.86%2.11B | -11.78%524M | -3.64%530M | -7.09%524M | 38.54%532M |
| Asset impairment expenditure | 584.62%178M | ---- | ---- | ---- | ---- | --26M | ---- | ---- | ---- | ---- |
| Provision for loans, leases and other losses | -3.83%3.62B | -50.43%755M | -12.03%797M | 49.50%1.05B | 61.24%1.01B | 72.68%3.76B | 241.48%1.52B | 84.15%906M | -31.09%705M | 188.94%627M |
| Deferred tax | -92.16%12M | -154.24%-147M | -152.74%-77M | 117.29%65M | 52.68%171M | 121.61%153M | 794.87%271M | 126.69%146M | -1,153.33%-376M | 221.74%112M |
| Change in working capital | -129.20%-4.01B | 5,517.47%9.33B | -482.95%-7.7B | -576.64%-6.75B | -91.73%1.11B | 601.74%13.73B | -84.46%166M | -115.25%-1.32B | 105.24%1.42B | -30.05%13.47B |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | 125.96%257M | ---- | ---- | ---- | ---- |
| -Change in loans | 726.83%16.87B | 242.95%11.35B | 64.39%-4.54B | -189.22%-7.99B | 99.39%18.05B | 91.38%-2.69B | -172.98%-7.94B | -81.66%-12.76B | 168.61%8.96B | 209.83%9.05B |
| -Change in other working capital | -227.12%-20.88B | -125.00%-2.03B | -127.54%-3.15B | 116.41%1.24B | -483.45%-16.94B | -51.95%16.42B | 63.22%8.11B | -27.03%11.44B | 46.02%-7.54B | -83.94%4.42B |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | -61.65%10.24B | 171.23%12.77B | -307.60%-4.21B | -180.07%-3.19B | -69.52%4.87B | 178.42%26.7B | 32.22%4.71B | -81.03%2.03B | 116.30%3.99B | -19.38%15.98B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 102.47%605M | 76.54%-2.01B | 97.81%-113M | -356.36%-4.61B | 158.15%7.34B | -15.94%-24.53B | -51.35%-8.56B | -232.63%-5.15B | 113.52%1.8B | -107.46%-12.62B |
| Proceeds payment in interest bearing deposits in bank | 65.83%854M | 3,784.21%1.4B | -223.64%-978M | 42.86%-20M | 322.66%452M | -69.35%515M | -105.03%-38M | 61.76%791M | 68.47%-35M | -137.18%-203M |
| Net PPE purchase and sale | -10.55%-1.73B | -15.51%-499M | 1.94%-405M | -34.25%-439M | 1.53%-386M | 6.74%-1.56B | 61.12%-432M | -117.37%-413M | -61.88%-327M | -125.29%-392M |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -21.91%-217M | 10.95%-179M | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- |
| Net investment purchase and sale | 106.30%1.48B | 64.04%-2.91B | 122.96%1.27B | -292.18%-4.15B | 160.48%7.27B | -287.59%-23.48B | -37.63%-8.09B | -241.12%-5.53B | 2.13%2.16B | -93.33%-12.02B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 102.47%605M | 76.54%-2.01B | 97.81%-113M | -356.36%-4.61B | 158.15%7.34B | -15.94%-24.53B | -51.35%-8.56B | -232.63%-5.15B | 113.52%1.8B | -107.46%-12.62B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 42.51%-8.67B | 56.67%-2.56B | -20.47%-2.64B | 61.89%-697M | 46.18%-2.77B | -5,728.73%-15.09B | -59.50%-5.91B | -743.46%-2.19B | -217.92%-1.83B | -292.02%-5.15B |
| Net issuance payments of debt | 10.08%-321M | 92.14%-85M | -248.29%-1.35B | 1,360.22%1.17B | 34.78%-60M | 88.48%-357M | 59.83%-1.08B | -67.81%909M | 96.46%-93M | 84.74%-92M |
| Net commonstock issuance | -4,861.76%-3.24B | -11,091.67%-1.32B | -5,170.59%-862M | -4,947.37%-921M | -780.00%-136M | -97.97%68M | -58.62%12M | 240.00%17M | 90.00%19M | -99.40%20M |
| Net preferred stock issuance | -22.63%865M | 50.00%-200M | 712.50%1.37B | --0 | ---300M | 72.53%1.12B | ---400M | --168M | --1.35B | --0 |
| Cash dividends paid | -31.02%-5.03B | -4.23%-1.23B | -3.86%-1.29B | -82.96%-1.22B | -72.21%-1.28B | -42.06%-3.84B | -80.03%-1.18B | -67.79%-1.25B | -5.52%-669M | -11.03%-745M |
| Net other financing activities | 92.15%-948M | 108.40%274M | 75.32%-504M | 111.33%276M | 77.07%-994M | -683.85%-12.07B | -740.46%-3.26B | 13.00%-2.04B | -150.72%-2.44B | ---4.34B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 42.51%-8.67B | 56.67%-2.56B | -20.47%-2.64B | 61.89%-697M | 46.18%-2.77B | -5,728.73%-15.09B | -59.50%-5.91B | -743.46%-2.19B | -217.92%-1.83B | -292.02%-5.15B |
| Net cash flow | ||||||||||
| Beginning cash position | -16.47%65.1B | -21.63%58.59B | -18.16%65.36B | 2.41%76.46B | -16.47%65.1B | -10.90%77.93B | -8.00%74.76B | 16.61%79.87B | -27.76%74.66B | -10.90%77.93B |
| Current changes in cash | 116.82%2.17B | 184.01%8.2B | -30.82%-6.96B | -314.81%-8.5B | 627.74%9.44B | -14.28%-12.91B | -68.30%-9.76B | -137.20%-5.32B | 110.93%3.96B | -110.89%-1.79B |
| Effect of exchange rate changes | 185.33%214M | 619.59%698M | -12.68%186M | -307.35%-2.6B | 229.52%1.93B | -95.75%75M | -96.07%97M | 113.86%213M | -9.34%1.25B | -170.86%-1.49B |
| End cash position | 3.67%67.48B | 3.67%67.48B | -21.63%58.59B | -18.16%65.36B | 2.41%76.46B | -16.47%65.1B | -16.47%65.1B | -8.00%74.76B | 16.61%79.87B | -27.76%74.66B |
| Free cash from | -66.14%8.51B | 186.97%12.27B | -385.86%-4.61B | -199.21%-3.63B | -71.23%4.49B | 217.65%25.14B | 41.51%4.28B | -84.35%1.61B | 114.72%3.66B | -19.87%15.59B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.